AU2001251137A1 - Methods and products for regulating cell motility - Google Patents

Methods and products for regulating cell motility

Info

Publication number
AU2001251137A1
AU2001251137A1 AU2001251137A AU5113701A AU2001251137A1 AU 2001251137 A1 AU2001251137 A1 AU 2001251137A1 AU 2001251137 A AU2001251137 A AU 2001251137A AU 5113701 A AU5113701 A AU 5113701A AU 2001251137 A1 AU2001251137 A1 AU 2001251137A1
Authority
AU
Australia
Prior art keywords
products
methods
cell motility
regulating cell
regulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251137A
Inventor
James E. Bear
Frank B. Gertler
Joseph J. Loureiro
Jurgen Wehland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Massachusetts Institute of Technology
Original Assignee
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum fuer Infektionsforschung HZI GmbH, Massachusetts Institute of Technology filed Critical Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Publication of AU2001251137A1 publication Critical patent/AU2001251137A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2001251137A 2000-04-03 2001-03-30 Methods and products for regulating cell motility Abandoned AU2001251137A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19456400P 2000-04-03 2000-04-03
US60194564 2000-04-03
PCT/US2001/010249 WO2001074853A2 (en) 2000-04-03 2001-03-30 Methods and products for regulating cell motility

Publications (1)

Publication Number Publication Date
AU2001251137A1 true AU2001251137A1 (en) 2001-10-15

Family

ID=22718067

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251137A Abandoned AU2001251137A1 (en) 2000-04-03 2001-03-30 Methods and products for regulating cell motility

Country Status (3)

Country Link
US (1) US6716597B2 (en)
AU (1) AU2001251137A1 (en)
WO (1) WO2001074853A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806805A1 (en) * 2000-03-22 2001-09-28 Centre Nat Rech Scient PEPTIDE SEQUENCE COMPRISING ONE OR MORE REASONS FOR BINDING PROTEINS OF THE ENA / VASP FAMILY AND USES THEREOF
US20050203578A1 (en) * 2001-08-15 2005-09-15 Weiner Michael L. Process and apparatus for treating biological organisms
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
DE10256706A1 (en) * 2002-12-04 2004-07-08 Leica Microsystems Wetzlar Gmbh Method for controlling an image recording and control device therefor
US8435959B2 (en) 2004-03-29 2013-05-07 University Of South Florida Effective treatment of tumors and cancer with triciribine and related compounds
US20110008327A1 (en) * 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
EP2399932B1 (en) 2005-05-12 2016-11-16 ZymoGenetics, Inc. Compositions and methods for modulating immune responses
GR20050100526A (en) * 2005-10-19 2007-05-23 B.S.R.C. "Alexander Fleming" Deregelated genes and/or processes in inflamatory arthritis.
CN1870631B (en) * 2005-11-11 2010-04-14 华为技术有限公司 Gate control method of media gateway
WO2008097466A2 (en) 2007-02-02 2008-08-14 Albert Einstein College Of Medicine Of Yeshiva University Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors
ES2632052T3 (en) * 2007-09-28 2017-09-08 Pfizer Inc. Addressing to cancer cells using nanoparticles
US8642277B2 (en) * 2009-09-10 2014-02-04 Albert Einstein College Of Medicine Of Yeshiva University Tumor microenvironment of metastasis (TMEM) and uses thereof in diagnosis, prognosis and treatment of tumors
WO2011093989A1 (en) * 2010-01-27 2011-08-04 Albert Einstein College Of Medicine Of Yeshiva University Methods for determining agents targeting mena isoforms and uses thereof for diagnosis and treatment of metastatic tumors
US20140220018A1 (en) * 2011-06-16 2014-08-07 Giovanni M. Pitari Biomarkers for epithelial cancer diagnosis and treatment
EP3481423A4 (en) * 2016-07-08 2020-07-22 Metastat, Inc. Methods and compositions for anticancer therapies that target mena protein isoforms kinases
WO2021030678A1 (en) * 2019-08-15 2021-02-18 University Of Massachusetts Targeting of the cytoskeleton as a therapeutic approach for neurodegenerative disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851786A (en) 1995-09-27 1998-12-22 National Jewish Center For Immunology And Respiratory Medicine Product and process to regulate actin polymerization
US5976819A (en) 1995-11-21 1999-11-02 National Jewish Medical And Research Center Product and process to regulate actin polymerization in T lymphocytes
WO1998001755A1 (en) 1996-07-05 1998-01-15 Fred Hutchinson Cancer Research Center Screening method for mena protein involved in microfilament dynamics
US5935850A (en) * 1996-09-30 1999-08-10 The Research Foundation Of State University Of New York Model for cell migration and use thereof
US5928882A (en) 1997-10-24 1999-07-27 The Rockefeller University Treatment and prevention of neurodegenerative diseases using modulators of Fe65
GB9723824D0 (en) 1997-11-11 1998-01-07 Actinova Ltd Cytostatic agents
US5912128A (en) 1998-02-20 1999-06-15 Incyte Pharmaceuticals, Inc. Human ena/VASP-like protein splice variant
JP4288436B2 (en) 1999-08-06 2009-07-01 大塚製薬株式会社 Cochineal pigment-containing beverage and method for preventing discoloration thereof
AU2001251266A1 (en) 2000-04-03 2001-10-15 The Regents Of The University Of California Promoting cell growth by inhibiting enabled proteins or their ligands

Also Published As

Publication number Publication date
WO2001074853A2 (en) 2001-10-11
US20020048813A1 (en) 2002-04-25
US6716597B2 (en) 2004-04-06
WO2001074853A3 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2001244625A1 (en) Cell culturing method and device
AU2001251137A1 (en) Methods and products for regulating cell motility
AU3399801A (en) Method and apparatus for destroying dividing cells
AU5520399A (en) Method and arrangement for switching cells
AU782917C (en) Cell division inhibitors and process for producing the same
AU2001263028A1 (en) Stream-cipher method and apparatus
AU2002211657A1 (en) Assessment system and method
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2001250036A1 (en) Microdroplet cell culture technique
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU6901200A (en) Form keys and method using form keys
AU2001279850A1 (en) Method and arrangement for studsystem
AU2001287934A1 (en) Document feeder and method
AU1703301A (en) Block copolymers and method for the production and utilization thereof
AU2001229770A1 (en) Improved research and development process
AU2001233932A1 (en) Method and composition
AU2001236718A1 (en) Bioreactor and related method
AU2001271870A1 (en) Reactor plate and method
AU6819598A (en) Anti-counterfeit method and product using the method
AU2002239775A1 (en) Chemical-library composition and method
AU2002245648A1 (en) Isogenic ss-catenin cell lines, and methods of making and using same
AU6574801A (en) Method and device for comminuting micro-organisms
AU2002256556A1 (en) Sea-trosy and related methods
AU2000274825A1 (en) Cosmetic method
AU2001283030A1 (en) Process for making 3-hydroxyalkanenitriles and hydroxyaminoalkanes